Hemostasis in Liver Cirrhosis and Hepatocellular Cancer
NCT06212635 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-01-19
Summary
Evaluating hemostasis in decompensated liver cirrhosis with novel hemostatic assays.
Conditions
- Hemostasis in Decompensated Liver Cirrhosis
- Inflammation in Decompensated Liver Cirrhosis
Interventions
- DIAGNOSTIC_TEST
-
T-TAS
Blood test, laboratory assays
Sponsors & Collaborators
-
Sahlgrenska University Hospital
collaborator OTHER -
Region Stockholm
lead OTHER_GOV
Principal Investigators
-
Maria Magnusson, MD, PhD · Region Stockholm, Karolinska Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-02
- Primary Completion
- 2026-12-01
- Completion
- 2028-12-01
- FDA Device
- Yes
Countries
- Sweden
Study Locations
More Related Trials
-
Plasma and Hemodynamic Markers During Hepatectomy
NCT01700231 ·Status: COMPLETED
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
Oxidative Stress and Haemostasis Abnormalities in Cirrhosis
NCT01607814 ·Status: UNKNOWN
-
Biochemical and Genetic Markers in Liver Diseases
NCT01706614 ·Status: UNKNOWN
-
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
NCT01825213 ·Status: COMPLETED
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NCT06681818 ·Status: RECRUITING ·Phase: NA
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
NCT05781568 ·Status: RECRUITING
-
DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
NCT07317193 ·Status: RECRUITING ·Phase: NA
-
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
NCT06236568 ·Status: RECRUITING ·Phase: NA
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
NCT04258566 ·Status: TERMINATED ·Phase: NA
-
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
NCT04800497 ·Status: RECRUITING
-
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
NCT03020342 ·Status: UNKNOWN
-
Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma
NCT03285867 ·Status: UNKNOWN
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness
NCT03352882 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
NCT04459468 ·Status: COMPLETED
-
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
NCT03129685 ·Status: UNKNOWN ·Phase: NA
-
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
NCT04221347 ·Status: UNKNOWN